A Phase I Study of AK138D1 in the Treatment of Advanced Solid Tumors
NCT06730386
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
100
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Cancer
Interventions
DRUG:
AK138D1
Sponsor
Akeso